Stephen Wu is a partner in the law firm of McDermott Will & Emery and is based in the Firm’s Chicago office. He focuses his practice on complex litigation, mergers and acquisitions, and counseling clients on healthcare antitrust and pricing and distribution issues. Stephen has represented clients in a wide variety of industries including: health care, biotechnology, information technology, aerospace, consumer products, energy, and food. Stephen has defended clients in litigation against federal and state antitrust and unfair competition claims, and represented clients in criminal antitrust investigations. For mergers and acquisitions, Stephen has defended transactions before the Federal Trade Commission (FTC) and the United States Department of Justice. Besides healthcare antitrust and pricing and distribution issues, Stephen has also counseled clients on standards-setting and compliance with consumer protection laws. Prior to joining the Firm, Stephen was an attorney for the FTC, where he participated in all aspects of the FTC’s merger enforcement program, from investigating multibillion dollar transactions to negotiating consent orders resolving the government’s competition concerns. At the FTC, he received an Award for Meritorious Service and its Stephen Nye Award, the FTC’s highest award given to a junior attorney, in 2001. Stephen is admitted to practice in Illinois and before the U.S. District Courts for the Northern and Southern Districts of Illinois, the Eastern District of Michigan, the Northern District of Ohio, and the United States Courts of Appeals for the Sixth and Seventh Circuits. Stephen is also a member of the American Bar Association’s Section of Antitrust Law, and has for several years served as a faculty member for the Practicing Law Institute’s Annual Antitrust Law Institute. He is also an active member of the Asian American Bar Association of Greater Chicago, including serving as a Board member of its Law Foundation.
73
A recent decision by the US Court of Appeals for the Sixth Circuit is important for competitors involved in joint ventures because it states what mode of antitrust analysis—the per se rule or the rule of reason—applies to the conduct of joint ventures when it is challenged as anticompetitive. The (...)
73
THE LATEST: DOJ Announces Settlement with Carolinas Health System (Atrium Health) After Two Years of Litigation* The Department of Justice (DOJ) announced last week that it and the State of North Carolina have reached a settlement with Carolinas Healthcare System / Atrium Health relating to (...)
221
A recent New York state appeals court decision highlights the need for suppliers to continue exercising caution when adopting and implementing a resale price maintenance policy. On May 8, 2012, the Appellate Division of the New York Supreme Court affirmed a lower court’s decision that (...)
202
New state law could affect implementation of minimum resale price maintenance programs. Suppliers should review their minimum resale price programs for their resellers in the United States following the passage of a new law in the State of Maryland prohibiting agreements that establish minimum (...)
131
District court case could affect implementation of minimum resale price maintenance programs. Sellers must still exercise great caution when designing minimum resale price programs for their resellers in the United States following the recently settled New York v. Herman Miller, Inc. case. (...)
19 avenue Jean Aicard
106 West 32nd Street, Suite 144
New York, NY, 10001, USA
